142 related articles for article (PubMed ID: 36549970)
1. Diagnostic Performance of PET/MRI in Breast Cancer: A Systematic Review and Bayesian Bivariate Meta-analysis.
Ruan D; Sun L
Clin Breast Cancer; 2023 Feb; 23(2):108-124. PubMed ID: 36549970
[TBL] [Abstract][Full Text] [Related]
2. Staging/restaging performance of F18-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in breast cancer: A review and meta-analysis.
Lin CY; Lin CL; Kao CH
Eur J Radiol; 2018 Oct; 107():158-165. PubMed ID: 30292261
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic role of 18F-FDG PET/MRI in the TNM staging of breast cancer: a systematic review and meta-analysis.
Lu XR; Qu MM; Zhai YN; Feng W; Gao Y; Lei JQ
Ann Palliat Med; 2021 Apr; 10(4):4328-4337. PubMed ID: 33894709
[TBL] [Abstract][Full Text] [Related]
4. What is the diagnostic performance of 18-FDG-PET/MR compared to PET/CT for the N- and M- staging of breast cancer?
Botsikas D; Bagetakos I; Picarra M; Da Cunha Afonso Barisits AC; Boudabbous S; Montet X; Lam GT; Mainta I; Kalovidouri A; Becker M
Eur Radiol; 2019 Apr; 29(4):1787-1798. PubMed ID: 30267154
[TBL] [Abstract][Full Text] [Related]
5. Comparison of whole-body 18F-FDG PET/CT and PET/MRI for distant metastases in patients with malignant tumors: a meta-analysis.
Zhang C; Liang Z; Liu W; Zeng X; Mo Y
BMC Cancer; 2023 Jan; 23(1):37. PubMed ID: 36624425
[TBL] [Abstract][Full Text] [Related]
6. Prospective evaluation of whole-body MRI and
Bruckmann NM; Sawicki LM; Kirchner J; Martin O; Umutlu L; Herrmann K; Fendler W; Bittner AK; Hoffmann O; Mohrmann S; Dietzel F; Ingenwerth M; Schaarschmidt BM; Li Y; Kowall B; Stang A; Antoch G; Buchbender C
Eur J Nucl Med Mol Imaging; 2020 Nov; 47(12):2816-2825. PubMed ID: 32333068
[TBL] [Abstract][Full Text] [Related]
7. Clinical utility of 18F-FDG-PET/MR for preoperative breast cancer staging.
Botsikas D; Kalovidouri A; Becker M; Copercini M; Djema DA; Bodmer A; Monnier S; Becker CD; Montet X; Delattre BM; Ratib O; Garibotto V; Tabouret-Viaud C
Eur Radiol; 2016 Jul; 26(7):2297-307. PubMed ID: 26477029
[TBL] [Abstract][Full Text] [Related]
8. F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging.
Gallowitsch HJ; Kresnik E; Gasser J; Kumnig G; Igerc I; Mikosch P; Lind P
Invest Radiol; 2003 May; 38(5):250-6. PubMed ID: 12750613
[TBL] [Abstract][Full Text] [Related]
9. Comparison of nodal staging between CT, MRI, and [
Morawitz J; Bruckmann NM; Dietzel F; Ullrich T; Bittner AK; Hoffmann O; Ruckhäberle E; Mohrmann S; Häberle L; Ingenwerth M; Abrar DB; Sawicki LM; Breuckmann K; Fendler WP; Herrmann K; Buchbender C; Antoch G; Umutlu L; Kirchner J
Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):992-1001. PubMed ID: 34476552
[TBL] [Abstract][Full Text] [Related]
10. MRI and FDG-PET/CT based assessment of axillary lymph node metastasis in early breast cancer: a meta-analysis.
Liang X; Yu J; Wen B; Xie J; Cai Q; Yang Q
Clin Radiol; 2017 Apr; 72(4):295-301. PubMed ID: 28139203
[TBL] [Abstract][Full Text] [Related]
11. Performance of Positron Emission Tomography and Positron Emission Tomography/Computed Tomography Using Fluorine-18-Fluorodeoxyglucose for the Diagnosis, Staging, and Recurrence Assessment of Bone Sarcoma: A Systematic Review and Meta-Analysis.
Liu F; Zhang Q; Zhu D; Liu F; Li Z; Li J; Wang B; Zhou D; Dong J
Medicine (Baltimore); 2015 Sep; 94(36):e1462. PubMed ID: 26356700
[TBL] [Abstract][Full Text] [Related]
12. Comparison of magnetic resonance imaging and 18-fludeoxyglucose positron emission tomography/computed tomography in the diagnostic accuracy of staging in patients with cholangiocarcinoma: A meta-analysis.
Huang X; Yang J; Li J; Xiong Y
Medicine (Baltimore); 2020 Aug; 99(35):e20932. PubMed ID: 32871859
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous whole-body ¹⁸F-FDG PET-MRI in primary staging of breast cancer: a pilot study.
Taneja S; Jena A; Goel R; Sarin R; Kaul S
Eur J Radiol; 2014 Dec; 83(12):2231-2239. PubMed ID: 25282709
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic performance of [
Mirshahvalad SA; Hinzpeter R; Kohan A; Anconina R; Kulanthaivelu R; Ortega C; Metser U; Veit-Haibach P
Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4205-4217. PubMed ID: 35705874
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer staging in a single session: whole-body PET/CT mammography.
Heusner TA; Kuemmel S; Umutlu L; Koeninger A; Freudenberg LS; Hauth EA; Kimmig KR; Forsting M; Bockisch A; Antoch G
J Nucl Med; 2008 Aug; 49(8):1215-22. PubMed ID: 18632831
[TBL] [Abstract][Full Text] [Related]
16.
Lamarca A; Barriuso J; Chander A; McNamara MG; Hubner RA; ÓReilly D; Manoharan P; Valle JW
J Hepatol; 2019 Jul; 71(1):115-129. PubMed ID: 30797051
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic efficacy of 18F-FDG-PET or PET/CT in breast cancer with suspected recurrence: a systematic review and meta-analysis.
Xiao Y; Wang L; Jiang X; She W; He L; Hu G
Nucl Med Commun; 2016 Nov; 37(11):1180-8. PubMed ID: 27428888
[TBL] [Abstract][Full Text] [Related]
18. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis: comparison of F-18 Fluorodeoxyglucose-positron emission tomography and bone scintigraphy in the detection of bone metastases in patients with breast cancer.
Shie P; Cardarelli R; Brandon D; Erdman W; Abdulrahim N
Clin Nucl Med; 2008 Feb; 33(2):97-101. PubMed ID: 18209527
[TBL] [Abstract][Full Text] [Related]
20. PET/CT and MRI for Identifying Axillary Lymph Node Metastases in Breast Cancer Patients: Systematic Review and Meta-Analysis.
Zhang X; Liu Y; Luo H; Zhang J
J Magn Reson Imaging; 2020 Dec; 52(6):1840-1851. PubMed ID: 32567090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
